November 2018 Performance
Well, I got walloped again in November as my portfolio was not able to escape the sell-off. I’m basically in hibernation mode with a ~ 13% cash position. I did come out of the cave today by initiating a position in Tesaro (Ticker: TSRO) via short puts, which is being acquired by GlaxoSmithKline (Ticker: GSK) for $75.00 in cash. This is the type of deal I like, a tender offer situation with low antitrust risk. I’m going to keep this post short as there really is nothing else new to report…
2018 Performance = +5.96% with the
running monthly returns as follows:
January +2.80%
February +2.82%
March -0.03%
April +2.10%
May +6.25%
June -1.51%
July +1.53%
January +2.80%
February +2.82%
March -0.03%
April +2.10%
May +6.25%
June -1.51%
July +1.53%
August +5.1%
September -0.60%
October -8.78%
November -3.00%
0 Comments:
Post a Comment
<< Home